Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/ IIIa and alpha(v)beta3 integrins - Tam, SH; Sassoli, PM; Jordan, RE (Circulation, 1998)